[1]. Lal, C.V. and N. Ambalavanan, Cellular and humoral biomarkers of Bronchopulmonary Dysplasia. Early Human Development, 2017. 105: p. 35-39.
[2]. Yilmaz, C., et al., Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia. Turk J Pediatr, 2017. 59(2): p. 122-129.
[3]. Alving, K., E. Weitzberg and J.M. Lundberg, Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J, 1993. 6(9): p. 1368-70.
[4]. Reddel, H.K., et al., An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med, 2009. 180(1): p. 59-99.
[5]. Dweik, R.A., et al., An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med, 2011. 184(5): p. 602-15.
[6]. Jobe, A.H. and E. Bancalari, Bronchopulmonary dysplasia. Am J Respir Crit Care Med, 2001. 163(7): p. 1723-9.
[7]. Gibson, E.L., Y. Vaucher and J.J. Corrigan, Eosinophilia in premature infants: relationship to weight gain. J Pediatr, 1979. 95(1): p. 99-101.
[8]. Capasso, L., et al., Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and Proteomics. Frontiers in Pediatrics, 2019. 7: p. 30_x000a_.
[9]. Eriksson, L., et al., Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia. Pediatr Pulmonol, 2014. 49(7): p. 665-72.
[10]. Lee, H.J., et al., Chorioamnionitis, respiratory distress syndrome and bronchopulmonary dysplasia in extremely low birth weight infants. J Perinatol, 2011. 31(3): p. 166-70.
[11]. Klinger, G., et al., Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics, 2010. 125(4): p. e736-40.
[12]. Shima, Y., S. Kumasaka and M. Migita, Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: comparison of different definitions of bronchopulmonary dysplasia/chronic lung disease. Pediatr Int, 2013. 55(5): p. 578-81.
[13]. Nobile, S., et al., New Insights on Early Patterns of Respiratory Disease among Extremely Low Gestational Age Newborns. Neonatology, 2017. 112(1): p. 53-59.
[14]. Fischer, H.S. and C. Buhrer, Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics, 2013. 132(5): p. e1351-60.
[15]. Choo-Wing, R., et al., Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol, 2007. 293(1): p. L142-50.
[16]. Yoon, B.H., et al., Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol, 1997. 177(4): p. 825-30.
[17]. Rocha, G., et al., Cord blood levels of IL-6, IL-8 and IL-10 may be early predictors of bronchopulmonary dysplasia in preterm newborns small for gestational age. Dis Markers, 2012. 33(1): p. 51-60.
[18]. Yilmaz, C., et al., Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia. Turk J Pediatr, 2017. 59(2): p. 122-129.
[19]. Szpecht, D., et al., The significance of IL-1beta +3953C>T, IL-6 -174G>C and -596G>A, TNF-alpha -308G>A gene polymorphisms and 86 bp variable number tandem repeat polymorphism of IL-1RN in bronchopulmonary dysplasia in infants born before 32 weeks of gestation. Cent Eur J Immunol, 2017. 42(3): p. 287-293.
[20]. Ehrhardt, H., et al., Absence of TNF-alpha enhances inflammatory response in the newborn lung undergoing mechanical ventilation. Am J Physiol Lung Cell Mol Physiol, 2016. 310(10): p. L909-18.
[21]. Gabriele, C., et al., Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study. Eur Respir J, 2012. 39(3): p. 567-72.
[22]. May, C., et al., Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed, 2009. 94(3): p. F205-9.
[23]. Akata, K., et al., Decreased Bronchial Eosinophilic Inflammation and Mucus Hypersecretion in Asthmatic Mice Lacking All Nitric Oxide Synthase Isoforms. Lung, 2016. 194(1): p. 121-124.
[24]. Huang, H., et al., IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2007. 292(5): p. L1147-L1154.
[25]. Munder, M., et al., Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol, 1999. 163(7): p. 3771-7.
[26]. Chibana, K., et al., IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells. Clinical & Experimental Allergy, 2008. 38(6): p. 936-946.
[27]. Yatera, K. and H. Mukae, Possible pathogenic roles of nitric oxide in asthma. Respiratory Investigation, 2019. 57(4): p. 295-297.
[28]. Fan, W., et al., Relationship of T lymphocytes, cytokines, immunoglobulin E and nitric oxide with otitis media with effusion in children and their clinical significances. Revista da Associacao Medica Brasileira, 2019. 65(7): p. 971-976.